Aetna's pharmacy change notice for July 1, 2025 lists Zepbound under "Endocrine and Metabolic, Antiobesity" as a removed drug, with orlistat, Qsymia, Saxenda, and Wegovy named as the formulary alternatives
The greater the starting weight, the larger the absolute benefit from intervention
Choosing Safe, Licensed Weight Loss Medications in the UK While Retatrutide represents an exciting area of research, it is not a treatment option at present
Medication Sourcing Strategy: Following the landmark March 2026 partnership between Hims and Novo Nordisk, Hims has pivoted toward providing FDA-approved Wegovy and Ozempic as its primary offering
It is also involved in numerous metabolic processes, including detoxification and immune system support